Cargando...
Economic evaluation of biosimilars for reimbursement purposes – what, when, how?
Background: Limited previous research and guidelines on the design of economic evaluation for biosimilars have led to unresolved methodological questions on how to assess biosimilars. Objectives: We want to raise awareness of and explore methodological issues for the economic evaluation of biosimila...
Guardado en:
| Publicado en: | J Mark Access Health Policy |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Routledge
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7144192/ https://ncbi.nlm.nih.gov/pubmed/32284827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2020.1739509 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|